A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Completed

Conditions studied: Herpes Simplex Infections, Human Papillomavirus, Epstein-Barr Virus Infections, Varicella-zoster Virus Infection, Cytomegalovirus Infections

In brief

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Key facts

Study ID

NCT02715752

Run by

The Center for the Biology of Chronic Disease

People needed

1000

Starts

2016-01-01

Expected to finish

2016-03-01

Last updated by the study team

2016-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Latent viral infection with either HSV, HPV, VZV, EBV, or CMV
• Taking Gene-Eden-VIR/Novirin

You may not qualify if…

• Use of other antiviral treatments

Where it is running

• The Center for the Biology of Chronic Disease — Valley Cottage, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.